Neurophet Participates RSNA 2025, Showcased Real-World Clinical Use Cases of ‘Neurophet AQUA AD’

5 days ago

Demonstrated brain imaging analysis solutions, including 'Neurophet AQUA AD,' which enables monitoring of adverse effects associated with Alzheimer's disease treatmentsHighlighted…

Whisker’s Litter-Robot Becomes the First Automatic Litter Box Eligible for HSA/FSA Spending

5 days ago

The milestone expands access to barrier-reducing cat care and builds on Whisker's mission to simplify pet parenting through thoughtful, intelligent…

Expion Health Announces Qlare™, a Breakthrough Conversational AI Tool Transforming Prescription Cost Decision-Making

5 days ago

NORTH BETHESDA, Md., Dec. 5, 2025 /PRNewswire/ -- Expion Health announced today the upcoming launch of Qlare™, a major advancement to…

November in Review: 10 Top Health Press Releases

5 days ago

A roundup of the most newsworthy healthcare press releases from PR Newswire, including new company mergers, Alzheimer's fundraising and advances…

Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement

5 days ago

ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary…

Medical Care Technologies Inc. (OTC Pink:MDCE) Closes Reg A – Dilution Ends, Growth Phase Begins

5 days ago

MESA, ARIZONA / ACCESS Newswire / December 5, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to announce…

Owlet Launches TGA-Approved Dream Sock™ in Australia & New Zealand, Expanding International Footprint and Bringing Trusted Pediatric Health Monitoring to More Families Worldwide

6 days ago

TGA approval enables regional launch of Owlet’s clinically validated, award-winning infant health monitor; Owlet360™ subscription marks first international expansion of…

CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines

6 days ago

Concludes Distribution Agreement with Gore® for VIABIL® in the United States and Canada, Effective January 1, 2026 Announces Intent to…

TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025

6 days ago

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with…